Reishi and Cancer Research
Explore mushroom research and guides on reishi and cancer research.
Ganoderma lucidum as a Cancer Adjunct: Clinical Evidence
Evidence for ganoderma lucidum as adjunct cancer therapy: a 2019 meta-analysis found HR 0.82 mortality reduction; Cochrane found 1.27x response enhancement.
Reishi and Breast Cancer: Research on Hormone-Sensitive Tumors
A 2012 RCT found reishi spore powder reduced fatigue and anxiety in breast cancer patients on endocrine therapy. Here's what the full evidence base shows.
Reishi and Cancer: What 50 Years of Research Tells Us
A 2019 meta-analysis found 18% lower mortality risk in cancer patients using reishi. Here is what five clinical trials and 50 years of research actually show.
Reishi Polysaccharides and Tumor Immune Surveillance
Reishi polysaccharides bind dectin-1 on immune cells and can raise MHC I on tumour cells in culture — but the human trials disagree with each other. Here is the whole record.